Q1 2025 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2025-05-15 · accession 0001172661-25-001939
$939.8M
Reported value
81
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $118.2M | 12.6% | 1,550,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $65.6M | 6.98% | 650,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $44.2M | 4.70% | 1,100,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $37.0M | 3.94% | 275,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $36.5M | 3.89% | 2,300,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $28.3M | 3.01% | 65,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $27.9M | 2.97% | 250,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $27.6M | 2.94% | 1,150,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $27.3M | 2.91% | 270,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $27.0M | 2.87% | 300,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $19.6M | 2.09% | 175,000 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $17.1M | 1.82% | 500,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $16.9M | 1.80% | 680,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $16.6M | 1.77% | 150,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $15.6M | 1.66% | 100,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $14.8M | 1.58% | 675,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $14.0M | 1.49% | 775,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $13.6M | 1.44% | 200,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $13.5M | 1.44% | 50,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $13.3M | 1.41% | 1,250,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $13.1M | 1.40% | 200,000 | CALL | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $12.8M | 1.37% | 145,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $12.6M | 1.34% | 60,000 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $12.4M | 1.32% | 250,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $12.1M | 1.29% | 150,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $10.8M | 1.15% | 60,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $10.4M | 1.10% | 65,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $10.3M | 1.09% | 200,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $9.4M | 1.00% | 35,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $9.1M | 0.96% | 125,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $8.8M | 0.94% | 250,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $8.1M | 0.86% | 12,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $7.8M | 0.83% | 200,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $7.7M | 0.82% | 500,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $7.6M | 0.81% | 1,050,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $7.6M | 0.81% | 300,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $7.6M | 0.81% | 250,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $7.5M | 0.80% | 45,000 | Common | SOLE |
| 941848103 | WAT | WATERS CORP | $7.4M | 0.78% | 20,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.3M | 0.78% | 115,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $6.8M | 0.73% | 100,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $6.7M | 0.71% | 200,000 | PUT | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $6.6M | 0.70% | 925,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.6M | 0.70% | 300,000 | CALL | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $6.1M | 0.65% | 100,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $6.1M | 0.64% | 600,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $6.0M | 0.63% | 1,400,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $5.9M | 0.63% | 200,000 | PUT | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $5.3M | 0.56% | 30,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $5.1M | 0.54% | 150,000 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $5.1M | 0.54% | 100,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $5.0M | 0.53% | 150,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.8M | 0.51% | 200,000 | CALL | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $4.7M | 0.50% | 450,000 | Common | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $4.7M | 0.50% | 20,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $4.6M | 0.49% | 20,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $4.2M | 0.45% | 175,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $4.2M | 0.45% | 125,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $4.0M | 0.43% | 125,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $3.7M | 0.40% | 200,000 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $3.7M | 0.39% | 50,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $3.6M | 0.39% | 40,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $3.6M | 0.39% | 150,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.5M | 0.37% | 100,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $3.4M | 0.36% | 2,000,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $3.3M | 0.35% | 10,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.3M | 0.35% | 275,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $3.0M | 0.32% | 500,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $2.6M | 0.28% | 200,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $2.5M | 0.27% | 20,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $2.5M | 0.26% | 575,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.2M | 0.24% | 175,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $2.1M | 0.22% | 700,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.9M | 0.21% | 700,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $1.8M | 0.19% | 800,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $1.4M | 0.15% | 500,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.2M | 0.13% | 850,000 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $1.1M | 0.12% | 167,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $864,000 | 0.09% | 400,000 | Common | SOLE |
| 696077502 | — | PALATIN TECHNOLOGIES INC | $582,900 | 0.06% | 1,000,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $553,070 | 0.06% | 700,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.